Review article · 2025 · Open access

A translational view of airway epithelial dysfunction in COPD

Christopher E Brightling, Mona Bafadhel, MeiLan King Han, Jean‐François Papon, Klaus Friedrich Rabe, Paola Rogliani, Dave Singh

European Respiratory Review, 34(178), 250110 · Published 1 October 2025 · DOI 10.1183/16000617.0110-2025

Open full textCite this paper

In brief

“A translational view of airway epithelial dysfunction in COPD” is a 2025 review article by Christopher E Brightling and 6 co-authors, published in European Respiratory Review. OpenAlex counts 24 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at European Respiratory Review.

Citations
24
Most cited in
2026 (23)
Field-weighted impact
2.97
References
175
Authors
7

Abstract

COPD is a heterogeneous, progressive inflammatory airway disease, with patients presenting with a wide variety of symptoms, comorbid conditions and underlying pathophysiology. Smoking is a major contributing factor to disease burden, alongside other environmental and patient-related risk factors. Airway inflammation is consistently present in COPD and is implicated in disease pathogenesis and progression. The airway epithelium functions as an active physiochemical barrier, protecting the lungs from pathogens and airborne environmental triggers, and as an immune organ that coordinates immunological activity in response to pollutant, bacterial, viral or allergen exposure. Inhalation of cigarette smoke and other airborne triggers can damage bronchial epithelial cells, leading to exaggerated inflammatory responses and airway remodelling. Airway inflammation in COPD, including neutrophilic and eosinophilic phenotypes, is mediated by the epithelium and epithelial cell-derived cytokines. Improving our understanding of epithelial-related inflammation in COPD is essential for the identification of novel biomarkers, stratification of patients, development of targeted therapeutics and creation of personalised treatment strategies. Here, we review the current understanding of the role of the airway epithelium in COPD pathogenesis, providing an overview of the pathological changes to the epithelium and the role of the epithelial-derived cytokines in driving different inflammatory phenotypes. We then consider biomarkers related to epithelial function in COPD and discuss how the epithelium might be targeted by novel COPD therapies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Brightling, C. E., Bafadhel, M., Han, M. K., Papon, J., Rabe, K. F., Rogliani, P., & Singh, D. (2025). A translational view of airway epithelial dysfunction in COPD. European Respiratory Review, 34(178), 250110. https://doi.org/10.1183/16000617.0110-2025

MLA 9

Brightling, Christopher E, et al. “A translational view of airway epithelial dysfunction in COPD.” European Respiratory Review, vol. 34, no. 178, 2025, p. 250110. https://doi.org/10.1183/16000617.0110-2025.

Chicago

Brightling, Christopher E, Mona Bafadhel, MeiLan King Han, Jean‐François Papon, Klaus Friedrich Rabe, Paola Rogliani, and Dave Singh. 2025. “A translational view of airway epithelial dysfunction in COPD.” European Respiratory Review 34 (178): 250110. https://doi.org/10.1183/16000617.0110-2025.

Harvard

Brightling, C. E. et al. (2025) ‘A translational view of airway epithelial dysfunction in COPD’, European Respiratory Review, 34(178), p. 250110. doi:10.1183/16000617.0110-2025.

IEEE

C. E. Brightling et al., “A translational view of airway epithelial dysfunction in COPD,” European Respiratory Review, vol. 34, no. 178, p. 250110, 2025, doi: 10.1183/16000617.0110-2025.

BibTeX

@article{brightling2025translational,
  title     = {{A translational view of airway epithelial dysfunction in COPD}},
  author    = {Brightling, Christopher E and Bafadhel, Mona and Han, MeiLan King and Papon, Jean‐François and Rabe, Klaus Friedrich and Rogliani, Paola and Singh, Dave},
  journal   = {European Respiratory Review},
  year      = {2025},
  volume    = {34},
  number    = {178},
  pages     = {250110},
  doi       = {10.1183/16000617.0110-2025},
  url       = {https://doi.org/10.1183/16000617.0110-2025}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research

  • chronic obstructive pulmonary disease
  • airway epithelium
  • epithelial dysfunction
  • airway inflammation
  • cigarette smoke
  • epithelial-derived cytokines
  • neutrophilic inflammation
  • eosinophilic inflammation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Brightling, C. E., Bafadhel, M., Han, M. K., Papon, J., Rabe, K. F., Rogliani, P., & Singh, D. (2025). A translational view of airway epithelial dysfunction in COPD. European Respiratory Review, 34(178), 250110. https://doi.org/10.1183/16000617.0110-2025

How many times has this paper been cited?

24 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at European Respiratory Review: sign in and open the full text from this page.

Who wrote this paper?

Christopher E Brightling, Mona Bafadhel, MeiLan King Han, Jean‐François Papon, Klaus Friedrich Rabe, Paola Rogliani, Dave Singh.

What is the DOI of this paper?

10.1183/16000617.0110-2025, permanently at https://doi.org/10.1183/16000617.0110-2025. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.